EMEA-002344-PIP02-18
Key facts
| Active substance |
liposomal ciclosporin A (L-CsA)
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0312/2019
|
| PIP number |
EMEA-002344-PIP02-18
|
| Pharmaceutical form(s) |
Powder for nebuliser solution
|
| Condition(s) / indication(s) |
Treatment of bronchiolitis obliterans syndrome
|
| Route(s) of administration |
Inhalation use
|
| Contact for public enquiries |
Breath Therapeutics GmbH
Tel. +49 8990414910 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|